Wirkung von propionibacterium granulosum KP-45 auf die abwehr von infektionen mit listeria monocytogenes und salmonella typhimurium

Adlam, 1972, Enhanced resistance of mice to infection with bacteria following pre-treatment with Corynebacterium parvum, Nature, 235, 219 Adlam, 1972, Lymphoreticular stimulatory properties of Corynebacterium parvum and related bacteria, J. med. Microbiol., 6, 261, 10.1099/00222615-6-3-261 Bany, 1984, Immunmodulation by Propionibacterium granulosum KP 45 and experimental trichinellosis in mice, Zbl. Bakt. Hyg., I. Abt. Orig. A, 256, 518 Dye, 1981, Mechanisms of anti-tumor activation of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations, J. exp. Med., 154, 609, 10.1084/jem.154.3.609 Fauve, 1971, Ann. Inst. Pasteur, 120, 399 Einger, 1978, Reversion of dextran sulfate-induced loss of antibacterial resistance by Bordetella pertussis, Infect. Immun., 19, 950, 10.1128/IAI.19.3.950-960.1978 Hahn, 1981, The role of cell-mediated immunity in bacterial infections, Rev. inf. Dis., 3, 1221, 10.1093/clinids/3.6.1221 Hof, 1982, The role of macrophages in primary and secondary infection of mice with Salmonella typhimurium, Ann. Immunol. (Inst. Pasteur), 133c, 21, 10.1016/0769-2625(82)90003-4 Howard, 1973, Cellular mechanisms underlying the adjuvant activity of Corynebacterium parvum: interactions of activated macrophages with T and B lymphocytes, 101 Kirchner, 1975, Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum, J. Immunol., 115, 1212 Kirchner, 1978, Protection of mice against viral infection by Corynebacterium parvum and Bordetella pertussis, J. gen. Virol., 41, 97, 10.1099/0022-1317-41-1-97 Ko, 1981, Comparative study on the immunostimulatory potency of different Propionibacterium strains, Med. Microbiol. Immunol., 170, 1, 10.1007/BF02123791 Mackaness, 1962, Cellular resistance to infection, J. exp. Med., 116, 381, 10.1084/jem.116.3.381 Ørskov, 1928, Studien über Breslauinfektionen der Mäuse, speziell mit Rücksicht auf die Bedeutung des Reticuloendothelialgewebes, Z. Immun.-Forsch., 55, 34 Pulverer, 1985, Immunomodulation by Propionibacteria, Clinical Immunology Newsletters, 6, 51, 10.1016/S0197-1859(85)80014-5 Roszkowski, 1985, Small-cell lung cancer and immunochemotherapy with Propionibacterium granulosum KP 45, J. Cancer Res. Clin. Oncol., 109, 72, 10.1007/BF01884258 Roszkowski, 1980, The correlation of susceptibility of different Propionibacterium strains to macrophage killing and antitumor activity, Med. Microbiol. Immunol., 169, 1, 10.1007/BF02123706 Roszkowski, 1980, Action of three species of Propionibacteria (P. granulosum, P. acnes, P. avidum) on experimental tumor systems in mice, Zbl. Bakt. Hyg., I. Abt. Orig. A, 246, 405 Roszkowski, 1980, Effect of three strains of Propionibacteria (P. granulosum, P. avidum, P. acnes) and cell-wall preparations on lymphocytes and macrophages, Zbl. Bakt. Hyg. I. Abt. Orig. A, 246, 393 Ruitenberg, 1975, Effect of Corynebacterium parvum on the course of Listeria monocytogenes infection in normal and congenitally athymic (nude) mice, Zbl. Bakt. Hyg., I. Abt. Orig. A, 231, 197 Scott, 1974, Corynebacterium parvum as an immunotherapeutic anticancer agent, Sem. Oncol., 1, 367 Swartzberg, 1975, Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum, Infect. Immun., 12, 1037, 10.1128/IAI.12.5.1037-1043.1975 Szmigielski, 1982, Antineoplastic and antiviral properties of Propionibacterium granulosum, Drugs exptl. Clin. Res., 8, 387 Szmigielski, 1983, Experimental and clinical experience with Propionibacteria in neoplastic and viral diseases, 31 Szmigielski, 1982, Experimental immunostimulation by Propionibacteria, 129 Wing, 1980, Decreased resistance to Listeria monocytogenes in mice injected with killed Corynebacterium parvum: association with suppression of cell-mediated immunity, J. Infect. Dis., 141, 203, 10.1093/infdis/141.2.203